Copy Number Variations in a Cohort of 420 Individuals with Neurodevelopmental Disorders From the South of Brazil

Chromosomal microarray (CMA) is now recommended as first tier for the evaluation in individuals with unexplained neurodevelopmental disorders (ND). However, in developing countries such as Brazil, classical cytogenetic tests are still the most used in clinical practice, as reflected by the scarcity...

Descripción completa

Detalles Bibliográficos
Autores principales: Chaves, Tiago Fernando, Baretto, Nathacha, Oliveira, Luan Freitas de, Ocampos, Maristela, Barbato, Ingrid Tremel, Anselmi, Mayara, De Luca, Gisele Rozone, Barbato Filho, Jorge Humberto, Pinto, Louise Lapagesse de Camargo, Bernardi, Pricila, Maris, Angelica Francesca
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6882836/
https://www.ncbi.nlm.nih.gov/pubmed/31780800
http://dx.doi.org/10.1038/s41598-019-54347-z

Ejemplares similares

Ejemplares similares